Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.39 |
| ▸ | FDPS | P14324 | 9/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2397669 | 1.00 | TSHR (0.44) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL1891306 | 1.00 | TSHR (0.44) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL517658 | 1.00 | TSHR (0.44) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL518405 | 1.00 | TSHR (0.44) | TSHRTHRBGGPS1FDPSEPHX1 | |
| Bromide SCHEMBL31470931 | 0.97 | TSHR (0.42) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL518098 | 0.97 | TSHR (0.39) | TSHRTHRBGGPS1FDPSSMPD1 | |
| SCHEMBL479334 | 0.90 | EPHX1 (0.38) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL18457877 | 0.90 | TSHR (0.40) | TSHRTHRBGGPS1FDPSEPHX1 | |
| SCHEMBL517449 | 0.88 | TSHR (0.35) | TSHRTHRBFDPSEPHX1 | |
| SCHEMBL3431417 | 0.86 | TSHR (0.35) | TSHRTHRBGGPS1FDPSEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9226925-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2016-01-05 | — | — | US | claimed |
| US-8940729-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-01-27 | — | — | US | claimed |
| US-8912217-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2014-12-16 | — | — | US | claimed |
| CN-106211748-B | Agrochemical oil-based concentrates | 禾大国际股份公开有限公司 | 2022-03-11 | — | — | CN | disclosed |
| US-20160207879-A1 | METHODS AND INDUSTRIAL PROCESSES FOR THE GENERATION OF FREE FATTY ACIDS AND DERIVATIVES THEREOF FROM OIL GUMS | INVENTURE RENEWABLES INC (US) | 2016-07-21 | — | — | US | disclosed |
| US-9226925-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2016-01-05 | — | — | US | disclosed |
| WO-2015050656-A2 | METHODS AND INDUSTRIAL PROCESSES FOR THE GENERATION OF FREE FATTY ACIDS DERIVATIVES THEREOF FROM OIL GUMS | INVENTURE RENEWABLES, INC. (US) | 2015-04-09 | — | — | WO | disclosed |
| US-8980880-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-03-17 | — | — | US | disclosed |
| US-8957067-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-02-17 | — | — | US | disclosed |
| US-8957212-B2 | Photobase generator | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-02-17 | — | — | US | disclosed |
| US-8940729-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2015-01-27 | — | — | US | disclosed |
| US-8716278-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2014-05-06 | — | — | US | disclosed |
| US-8716337-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2014-05-06 | — | — | US | disclosed |
| US-8653106-B2 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2014-02-18 | — | — | US | disclosed |
| US-8653065-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2014-02-18 | — | — | US | disclosed |
| US-20130338229-A1 | Abuse-Deterrent Methadone for the Safe Treatment of Drug Abuse and Pain Relief | Pisgah National Laboratories, Inc. (US) | 2013-12-19 | — | — | US | disclosed |
| US-8586575-B1 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder | PISGAH LABORATORIES, INC. (US) | 2013-11-19 | — | — | US | disclosed |
| US-20120028960-A1 | ABUSE DETERRENT AND ANTI-DOSE DUMPING PHARMACEUTICAL SALTS USEFUL FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER | PISGAH LABORATORIES, INC. | 2012-02-02 | — | — | US | disclosed |
| US-20110233048-A1 | PHOTOBASE GENERATOR | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
| EP-2368875-A1 | PHOTOBASE GENERATOR | Wako Pure Chemical Industries, Ltd. (JP) | 2011-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130338229-A1 | Abuse-Deterrent Methadone for the Safe Treatment of Drug Abuse and Pain Relief | OPRM1, OGFR, OPRK1 | TSHR 2195/4885THRB 1392/4885GGPS1 4312/4885 |
| US-20110233048-A1 | PHOTOBASE GENERATOR | CYBA, CRY1, GNB1 | TSHR 3162/4885THRB 3653/4885GGPS1 174/4885 |
| US-20120028960-A1 | ABUSE DETERRENT AND ANTI-DOSE DUMPING PHARMACEUTICAL SALTS USEFUL FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER | COMT, SLC6A3, SLC6A2 | TSHR 2160/4885THRB 710/4885GGPS1 4293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.